Revive Therapeutics Stock Analysis
| RVVTF Stock | USD 0.01 0 14.29% |
Revive Therapeutics is undervalued with Real Value of 0.006639 and Hype Value of 0.007557. The main objective of Revive Therapeutics otc analysis is to determine its intrinsic value, which is an estimate of what Revive Therapeutics is worth, separate from its market price. There are two main types of Revive Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Revive Therapeutics otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Revive Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Revive |
Revive OTC Stock Analysis Notes
The book value of the company was at this time reported as 0.03. The company recorded a loss per share of 0.06. Revive Therapeutics had not issued any dividends in recent years. Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Revive Therapeutics is traded on OTC Exchange in the United States.The quote for Revive Therapeutics is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Revive Therapeutics contact Michael Frank at 888 901 0036 or learn more at https://www.revivethera.com.Revive Therapeutics Investment Alerts
| Revive Therapeutics had very high historical volatility over the last 90 days | |
| Revive Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (17.81 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revive Therapeutics has accumulated about 5.29 M in cash with (13.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Revive Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 36.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Revive Therapeutics's market, we take the total number of its shares issued and multiply it by Revive Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 16th of March 2025, Revive Therapeutics holds the Risk Adjusted Performance of 0.0498, coefficient of variation of 2142.21, and Semi Deviation of 6.67. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Revive Therapeutics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Revive Therapeutics, which can be compared to its competitors. Please check Revive Therapeutics coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Revive Therapeutics is priced some-what accurately, providing market reflects its current price of 0.006 per share. As Revive Therapeutics appears to be a penny stock we also advise to check out its total risk alpha numbers.Revive Therapeutics Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Revive Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Revive Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Revive Therapeutics Outstanding Bonds
Revive Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Revive Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Revive bonds can be classified according to their maturity, which is the date when Revive Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Revive Therapeutics Predictive Daily Indicators
Revive Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Revive Therapeutics otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Revive Therapeutics Forecast Models
Revive Therapeutics' time-series forecasting models are one of many Revive Therapeutics' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Revive Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Revive OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Revive Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Revive shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Revive Therapeutics. By using and applying Revive OTC Stock analysis, traders can create a robust methodology for identifying Revive entry and exit points for their positions.
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Revive Therapeutics is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Revive Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Complementary Tools for Revive OTC Stock analysis
When running Revive Therapeutics' price analysis, check to measure Revive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revive Therapeutics is operating at the current time. Most of Revive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Revive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revive Therapeutics' price. Additionally, you may evaluate how the addition of Revive Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |